- Home
- MPX vs EDIT Comparison
MPX vs EDIT Comparison
Compare MPX & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- EDIT
- Stock Information
- Founded
- MPX 1965
- EDIT 2013
- Country
- MPX United States
- EDIT United States
- Employees
- MPX N/A
- EDIT N/A
- Industry
- MPX Marine Transportation
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPX Industrials
- EDIT Health Care
- Exchange
- MPX Nasdaq
- EDIT Nasdaq
- Market Cap
- MPX 306.9M
- EDIT 269.8M
- IPO Year
- MPX N/A
- EDIT 2016
- Fundamental
- Price
- MPX $9.00
- EDIT $3.17
- Analyst Decision
- MPX
- EDIT Buy
- Analyst Count
- MPX 0
- EDIT 11
- Target Price
- MPX N/A
- EDIT $4.56
- AVG Volume (30 Days)
- MPX 21.7K
- EDIT 3.2M
- Earning Date
- MPX 10-30-2025
- EDIT 10-31-2025
- Dividend Yield
- MPX 6.22%
- EDIT N/A
- EPS Growth
- MPX N/A
- EDIT N/A
- EPS
- MPX 0.40
- EDIT N/A
- Revenue
- MPX $224,368,000.00
- EDIT $38,901,000.00
- Revenue This Year
- MPX $3.97
- EDIT N/A
- Revenue Next Year
- MPX $13.02
- EDIT N/A
- P/E Ratio
- MPX $22.51
- EDIT N/A
- Revenue Growth
- MPX N/A
- EDIT N/A
- 52 Week Low
- MPX $7.49
- EDIT $0.91
- 52 Week High
- MPX $10.32
- EDIT $4.54
- Technical
- Relative Strength Index (RSI)
- MPX 55.04
- EDIT 42.68
- Support Level
- MPX $8.45
- EDIT $3.48
- Resistance Level
- MPX $9.24
- EDIT $3.87
- Average True Range (ATR)
- MPX 0.26
- EDIT 0.35
- MACD
- MPX 0.05
- EDIT -0.11
- Stochastic Oscillator
- MPX 75.15
- EDIT 4.92
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.